Janus Henderson Capital Funds Plc - Global Life Sciences Fund

Global life-sciences equity strategy focused on innovative healthcare companies addressing significant unmet medical needs.$5.8B AUM6 published ideas

The fund invests at least 80% of its assets in life-sciences-oriented equities globally. The investment team focuses on innovative biotechnology, pharmaceutical, healthcare-services and medical-technology companies, using proprietary probability models, physician surveys and prescription models to assess clinical and commercial potential.

www.janushenderson.com ↗

Ideas from Janus Henderson Capital Funds Plc - Global Life Sciences Fund

LongARGXAug 2026

argenx SE

Argenx was a leading contributor during August following positive phase 3 results for Vyvgart in autoimmune myositis. The treatment significantly improved muscle strength and…

All ARGX ideas

LongPRAXAug 2026

Praxis Precision Medicines, Inc.

Praxis contributed positively after favourable regulatory updates on two key pipeline programs. FDA mid-cycle reviews identified no major safety or efficacy concerns for…

All PRAX ideas

LongPTGXAug 2026

Protagonist Therapeutics, Inc.

Protagonist Therapeutics is an existing portfolio holding benefiting from progress in its drug pipeline. During August, the FDA approved a hepcidin mimetic associated with the…

All PTGX ideas